Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395

BeOne Medicines · with Fortrea · NCT07820891

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–65 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
24
US sites recruiting
1
Study start
September 25, 2026
Record last updated
October 23, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This study will enroll healthy participants to evaluate whether BGB-43395 interacts with other drugs, including midazolam, celecoxib, dabigatran, and rosuvastatin.

Being studied: BGB-43395; Midazolam; Celecoxib; Dabigatran etexilate; Rosuvastatin

Conditions: Healthy Adult Participants

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Body mass index between 18.0 and 32.0 kg/m\^2, inclusive.
  • In good health, as determined by no clinically significant findings from medical history, 12-lead electrocardiogram and vital signs measurements, and clinical laboratory assessments.
  • Participants must not be pregnant or lactating and must agree to use contraception.

Exclusion Criteria

  • Significant history or clinical manifestation of any metabolic, allergic, dermatological, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, neurological, respiratory, endocrine, or psychiatric disorder, as determined by the investigator
  • History of stomach or intestinal surgery or resection that would potentially alter absorption and/or excretion of orally administered drugs
  • Confirmed systolic blood pressure >140 or \<90 mmHg, diastolic blood pressure >90 or \<50 mmHg, or pulse rate >100 or \<40 beats per minute.

Note: Other protocol-defined inclusion and exclusion criteria may apply.

Recruiting US locations

Study contacts (from the official record)

  • Study Director · 877-828-5568 · clinicaltrials@beonemed.com
A Trial in Healthy Participants to Assess Drug Interaction… (NCT07820891) | Bored Studies